If you are comparing GHK-Cu vs BPC-157 and sourcing in Canada, The Peptide Labs offers both formats for research use: Benefits of a Canadian Supplier Faster domestic shipping Reduced customs friction Easier repeat ordering for multi-week research cycles Cleaner inventory planning for protocol-based research FAQ: GHK-Cu vs BPC-157 Is GHK-Cu or BPC-157 better for skin
your bodys reaction to the treatment (this part is somewhat unpredictable unless youve tried other similar treatments in the past, and then that can give us some indication of how good your body is at responding to these treatments)
PMID: 29087650
Protocol 3: Comprehensive approach (advanced, with medical supervision) Goal: Full-spectrum immune modulation with organ support Phase 1 (Weeks 1-4): Foundation Thymosin alpha-1: 1.6 mg subcutaneously, three times weekly BPC-157: 300 mcg subcutaneously, twice daily Phase 2 (Weeks 5-12): Add modulation Continue Phase 1 peptides Add KPV: 300-500 mcg subcutaneously, once daily Add Selank: 500 mcg intranasally, once daily Phase 3 (Weeks 13-16): Organ support cycle Continue Phase 2 peptides Add Thymalin: 10 mg course over 10 days Add targeted bioregulators based on affected organs (kidney, cardiac, vascular as needed) Phase 4 (Weeks 17-20): Rest and assess Discontinue all peptides Monitor disease activity markers Assess sustained benefits Plan next cycle based on results Monitoring: Full labs every 4 weeks, including CBC, CMP, complement levels, anti-dsDNA, CRP, ESR, urine protein/creatinine ratio
Conclusion Safe handling ensures reliable outcomes during medication preparation routines
Umayr Azimi, is board-certified in obesity medicine and internal medicine